ASTRAZENECA
AstraZeneca is an innovation-driven biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines that make a meaningful difference in healthcare. AstraZeneca discovers new medicines that are designed to improve the health and quality of life of patients around the world - medicines that are innovative, effective, and which offer added benefits such as reduced side effects or better ways of taking the treatment. AstraZeneca focuses on getting the best from every medicine they make by exploring all the ways it can be used or improved. AstraZeneca was established on April 6, 1999, in Cambridgeshire, United Kingdom.
ASTRAZENECA
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical Precision Medicine
Founded:
1999-04-06
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.astrazeneca.com
Total Employee:
10001+
Status:
Active
Contact:
+44 20 3749 5000
Total Funding:
5.27 B USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Font API Google Maps Content Delivery Network LetsEncrypt Amazon
Similar Organizations
AbbVie
AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.
Bristol Myers Squibb
Bristol Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals.
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Novartis
Novartis is a healthcare company that provides solutions to address the evolving needs of patients worldwide.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Pfizer
Pfizer provides access to safe and effective and affordable medicines and health care services.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Roche
Roche is a pharmaceutical and diagnostics company that focuses on improving people’s lives.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2024-03-19 | Fusion Pharmaceuticals | Fusion Pharmaceuticals acquired by AstraZeneca | 2.4 B USD |
| 2024-03-14 | Amolyt Pharma | Amolyt Pharma acquired by AstraZeneca | 1.05 B USD |
| 2024-02-22 | Gracell Biotechnologies | Gracell Biotechnologies acquired by AstraZeneca | N/A |
| 2023-12-12 | Icosavax | Icosavax acquired by AstraZeneca | 1.1 B USD |
| 2023-01-09 | CinCor Pharma | CinCor Pharma acquired by AstraZeneca | 1.8 B USD |
| 2022-11-02 | Neogene Therapeutics | Neogene Therapeutics acquired by AstraZeneca | 320 M USD |
| 2022-07-05 | TeneoTwo | TeneoTwo acquired by AstraZeneca | 100 M USD |
| 2021-09-29 | Caelum Biosciences | Caelum Biosciences acquired by AstraZeneca | 500 M USD |
| 2020-12-12 | Alexion Pharmaceuticals | Alexion Pharmaceuticals acquired by AstraZeneca | 39 B USD |
| 2016-04-16 | Takeda Respiratory Business | Takeda Respiratory Business acquired by AstraZeneca | 575 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-07-16 | Huma | AstraZeneca investment in Series D - Huma | 80 M USD |
| 2024-07-08 | SmartCella | AstraZeneca investment in Private Equity Round - SmartCella | 50 M EUR |
| 2024-06-05 | Nucleus RadioPharma | AstraZeneca investment in Series A - Nucleus RadioPharma | N/A |
| 2024-05-22 | SixPeaks Bio | AstraZeneca investment in Series A - SixPeaks Bio | 30 M USD |
| 2024-05-22 | SixPeaks Bio | AstraZeneca investment in Debt Financing - SixPeaks Bio | 80 M USD |
| 2024-04-16 | Asher Bio | AstraZeneca investment in Series C - Asher Bio | 55 M USD |
| 2023-11-01 | Cellectis | AstraZeneca investment in Post-IPO Equity - Cellectis | 140 M USD |
| 2022-12-08 | GenAssist Therapeutics | AstraZeneca investment in Series A - GenAssist Therapeutics | N/A |
| 2022-11-29 | Rgenta Therapeutics | AstraZeneca investment in Series A - Rgenta Therapeutics | 52 M USD |
| 2022-11-28 | ZSHK Laboratories | AstraZeneca investment in Series B - ZSHK Laboratories | 90 M CNY |
Newest Events participated
Participated in Nordic life science Days 2017
on 2017-09-12 as sponsor
Participated in impact'17
on 2017-05-31 as sponsor
Key Employee Changes
Official Site Inspections
http://www.astrazeneca.com Semrush global rank: 74.56 K Semrush visits lastest month: 758.6 K
- Host name: ac9efcde36061855b.awsglobalaccelerator.com
- IP address: 15.197.255.153
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AstraZeneca"
AstraZeneca - Research-Based BioPharmaceutical Company
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.See details»
Leadership - Our Company - AstraZeneca
AstraZeneca - Wikipedia
AstraZeneca's reputation in China was tarnished following the failure of its Chinese subsidiary to timely donate to relief efforts following the 2008 Sichuan earthquake. Typically, donations for disaster relief in China are made through funds established through the Chinese Ministry of Civil Affairs and its subordinate organization the Red Cross Society of China. AstraZeneca had a corporate rul…See details»
AstraZeneca - The Org
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines. AstraZeneca is a global, science-led biopharmaceutical company that focuses …See details»
AstraZeneca Canada
Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product …See details»
Our Company - AstraZeneca
As an organization, we are driven by our purpose to push the boundaries of science and deliver life-changing medicines. Our purpose underpins everything we do. It gives us a reason to …See details»
Org Chart AstraZeneca - The Official Board
The organizational chart of AstraZeneca displays its 419 main executives including Pascal Soriot, Aradhana Sarin, Marc Dunoyer and Helen MacPhee. Toggle navigation The Official Board. Search. Search. Search by segment. …See details»
About us - AstraZeneca
Discover how at AstraZeneca, difference is valued, and our teams aim to reflect the diversity of our communities. Application Hints & Tips. Discover our Recruiter’s tops insights to navigating our application process. Our Locations. …See details»
AstraZeneca announces organisational changes
Jan 7, 2019 Ruud joined AstraZeneca in 1997 and has held various senior commercial and leadership roles, including as EVP, Europe, Regional Vice-President of AstraZeneca’s …See details»
AstraZeneca - Crunchbase Company Profile & Funding
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines that make a meaningful difference in …See details»
AstraZeneca | World Economic Forum
Feb 28, 2023 The World Economic Forum is an independent international organization committed to improving the state of the world by engaging business, political, academic and …See details»
AstraZeneca Management Team | Org Chart - RocketReach
AstraZeneca employs 74,059 employees. The AstraZeneca management team includes Kellie Assoc (PA to Country President) , Heather Stewart (Dep. Chief Compliance Officer, VP Ethics …See details»
AstraZeneca US
Nov 25, 2024 At AstraZeneca, we are leading a revolution in oncology to redefine cancer care for the millions of Americans living with cancer. It’s a lofty ambition. But we know that as with …See details»
AstraZeneca Open Innovation | Innovation through collaboration
At AstraZeneca, we know that to address all the issues facing healthcare and achieve the scientific breakthroughs we aspire to, collaboration is essential. Through our Open Innovation …See details»
AstraZeneca Announces Organizational Changes - Pharma's …
AstraZeneca is today announcing organisational changes to support continued scientific innovation and commercial success in the main therapy areas as the Company enters a new …See details»
Requesting Support − Sponsorships, Grants & Donations
AstraZeneca is committed to making a positive impact for people, society and the planet, including by providing grants, sponsorships, community investments and donations to organizations …See details»
Our people - AstraZeneca
Within our Oncology business, we strive to advance medicines through robust research and scientific partnerships. With a broad pipeline of next-generation medicines focused on a whole …See details»
Focus on next-gen therapeutics, AstraZeneca to restructure …
2 days ago AstraZeneca stated that it is committed to transforming patient outcomes in the country. Its global portfolio includes over 20 novel therapies spanning various disease areas, …See details»
Great place to work – Our company - AstraZeneca
They guide our decision making, define our beliefs and help foster a strong culture at AstraZeneca. We follow the science . Pushing the boundaries of science and working …See details»
A timeline of our company history | AstraZeneca
Important notice for users You are about to access AstraZeneca historic archive material. Any reference in these archives to AstraZeneca products or their uses may not reflect current …See details»